Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Lagerung
-20 °C
Informationen zur Lagerung
Shipped at 4°C. Store at -20°C for one year.
Haltbarkeit
12 months
Target
VWA5A
(Von Willebrand Factor A Domain Containing 5A (VWA5A))
Synonyme
VWA5A Peptide, LOH11CR2A Peptide, MGC68953 Peptide, loh11cr2a Peptide, BCSC-1 Peptide, BCSC1 Peptide, 5830475I06Rik Peptide, AW552491 Peptide, E130119J22 Peptide, Loh11cr2a Peptide, masa-1 Peptide, loss of heterozygosity, 11, chromosomal region 2, gene A Peptide, von Willebrand factor A domain containing 5A Peptide, von Willebrand factor A domain containing 5A S homeolog Peptide, LOH11CR2A Peptide, VWA5A Peptide, vwa5a.S Peptide, vwa5a Peptide, Vwa5a Peptide
Hintergrund
BCSC1, LOH11CR2A, von Willebrand factor A domain-containing protein 5A, Breast cancer suppressor candidate 1, BCSC-1, Loss of heterozygosity 11 chromosomal region 2 gene A protein